Efficacy of Annual Colonoscopic Surveillance in Individuals With Hereditary Nonpolyposis Colorectal Cancer

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 2, 2010, Pages 174-182

  Engel, Christoph ^a   Rahner, Nils ^b   Schulmann, Karsten ^c   Holinski Feder, Elke ^d   Goecke, Timm O ^e   Schackert, Hans K ^f   Kloor, Matthias ^g   Steinke, Verena ^b   Vogelsang, Holger ^h   Möslein, Gabriela ⁱ   Görgens, Heike ^f   Dechant, Stefan ^j   von Knebel Doeberitz, Magnus ^g   Rüschoff, Josef ^j   Friedrichs, Nicolaus ^b   Büttner, Reinhard ^b   Loeffler, Markus ^a   Propping, Peter ^b   Schmiegel, Wolff ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Center of Medical Genetics and Primary Health Care   (Armenia)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ St Josefs Hospital   (Germany)

^j UNIVERSITY OF REGENSBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER STAGING; CLINICAL FEATURE; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 75349092528     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.10.003     Document Type: Article

References (32)

1. Aarnio M., Mecklin J.P., Aaltonen L.A., et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64 (1995) 430-433
2. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
3. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6 (1997) 105-110
4. Wijnen J.T., Vasen H.F., Khan P.M., et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339 (1998) 511-518
5. Watson P., Vasen H.F., Mecklin J.P., et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123 (2008) 444-449
6. Burn J., Bishop D.T., Mecklin J.P., et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359 (2008) 2567-2578
7. de Jong A.E., Hendriks Y.M., Kleibeuker J.H., et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130 (2006) 665-671
8. Dove-Edwin I., Sasieni P., Adams J., et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331 (2005) 1047
9. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 (2000) 829-834
10. Jarvinen H.J., Mecklin J.P., and Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108 (1995) 1405-1411
11. de Vos tot Nederveen Cappel W.H., Nagengast F.M., Griffioen G., et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45 (2002) 1588-1594
12. Mecklin J.P., Aarnio M., Laara E., et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133 (2007) 1093-1098
13. Dove-Edwin I., de Jong A.E., Adams J., et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 130 (2006) 1995-2000
14. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44 (2007) 353-362
15. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
16. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89 (1997) 1758-1762
17. Mangold E., Pagenstecher C., Friedl W., et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 116 (2005) 692-702
18. Bressler B., Paszat L.F., Chen Z., et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132 (2007) 96-102
19. Bressler B., Paszat L.F., Vinden C., et al. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 127 (2004) 452-456
20. East J.E., Suzuki N., Stavrinidis M., et al. Narrow band imaging for colonoscopic surveillance in hereditary nonpolyposis colorectal cancer. Gut 57 (2008) 65-70
21. Hurlstone D.P., Karajeh M., Cross S.S., et al. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study. Am J Gastroenterol 100 (2005) 2167-2173
22. Lecomte T., Cellier C., Meatchi T., et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol 3 (2005) 897-902
23. Vasen H.F., Wijnen J.T., Menko F.H., et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110 (1996) 1020-1027
24. Liljegren A., Barker G., Elliott F., et al. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. J Clin Oncol 26 (2008) 3434-3439
25. Lindor N.M., Rabe K., Petersen G.M., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 (2005) 1979-1985
26. Grabowski M., Mueller-Koch Y., Grasbon-Frodl E., et al. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test 9 (2005) 138-146
27. Mecklin J.P., Jarvinen H.J., Aukee S., et al. Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol 22 (1987) 449-453
28. Fitzgibbons Jr. R.J., Lynch H.T., Stanislav G.V., et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 206 (1987) 289-295
29. Lanspa S.J., Jenkins J.X., Cavalieri R.J., et al. Surveillance in Lynch syndrome: how aggressive?. Am J Gastroenterol 89 (1994) 1978-1980
30. Box J.C., Rodriguez-Bigas M.A., Weber T.K., et al. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 42 (1999) 717-721
31. Lee J.S., Petrelli N.J., and Rodriguez-Bigas M.A. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg 181 (2001) 207-210
32. Central Research Institute of Ambulatory Health Care in Germany. Fourth annual report of screening colonoscopy in Germany, 2008. http://www.zi-berlin.de/koloskopie/downloads.php Accessed August 1, 2008